Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy for malignant gliomas

A P Kyritsis1

  • 1Department of Neuro-Oncology, University of Texas M.D. Anderson Cancer Center, Houston.

Oncology (Williston Park, N.Y.)
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note to: Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma.

Oncogene·2025
Same author

Restless legs syndrome and cerebrovascular/cardiovascular events: Systematic review and meta-analysis.

Acta neurologica Scandinavica·2017
Same author

The diagnostic yield of transesophageal echocardiography in patients with cryptogenic cerebral ischaemia: a meta-analysis.

European journal of neurology·2016
Same author

Apolipoprotein E polymorphisms and ischaemic stroke: a two-center Greek study.

European journal of neurology·2014
Same author

Cerebral sinus venous thrombosis in inflammatory bowel diseases.

QJM : monthly journal of the Association of Physicians·2012
Same author

Voxel-based diffusion tensor imaging detects pyramidal tract degeneration in primary lateral sclerosis.

The British journal of radiology·2010

Malignant glioma incidence is rising, with chemotherapy showing limited efficacy, especially for glioblastomas. New treatment strategies are urgently needed for this aggressive brain cancer.

Area of Science:

  • Neuro-oncology
  • Cancer Chemotherapy

Background:

  • Malignant glioma incidence has increased over the past two decades.
  • Chemotherapy offers survival benefits for malignant gliomas, particularly oligodendrogliomas and anaplastic astrocytomas.
  • Glioblastomas exhibit relative resistance to current treatment modalities.

Purpose of the Study:

  • To review the efficacy of current chemotherapy agents and combinations against malignant gliomas.
  • To highlight the differential chemosensitivity among glioma subtypes.
  • To underscore the need for novel therapeutic strategies.

Main Methods:

  • Review of existing literature on malignant glioma chemotherapy.
  • Analysis of treatment outcomes for various chemotherapy agents and combinations.

Related Experiment Videos

  • Comparison of efficacy across different glioma subtypes.

    • Main Results:

    • Carmustine, procarbazine, and eflornithine are among the most active agents.
    • Combinations like lomustine, procarbazine, vincristine, and thioguanine, dibromodulcitol, procarbazine, lomustine, fluorouracil, hydroxyurea show activity.
    • Glioblastomas remain a significant challenge due to treatment resistance.

    Conclusions:

    • Chemotherapy has demonstrated partial efficacy in treating malignant gliomas.
    • Significant challenges remain, particularly in treating glioblastomas.
    • Development of innovative therapeutic strategies is crucial for improving patient outcomes.